SEO URLwww.firestrike.ai/deals/vivtex-novo-nordisk-acquisition-2026
acquisitionAnnounced · Feb 25, 2026PharmaceuticalSource · CredibleArticle · Factual
Novo Nordisk acquires Vivtex
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$2.1B
Target
Vivtex
Cambridge, Massachusetts
Acquirer
Novo Nordisk
Financial Stake
Status
Announced
Novo Nordisk agreed to acquire Vivtex. Reported deal value: $2.1B. Status: Announced. Sector: Pharmaceutical. Target headquarters context: Cambridge, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-02-25. Figures and status may change as filings and press coverage update.
Danish pharmaceutical company Novo Nordisk is entering into a partnership with Vivtex to develop the next generation of oral biological drugs for obesity and diabetes
Deal timeline
Announced
Feb 25, 2026 · au.marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceutical with a reported deal value of $2.1B. Figures and status may change as sources update.
Sources: au.marketscreener.com · Primary article · FireStrike proprietary index